NASDAQ:ARYA

ARYA Sciences Acquisition Corp III (ARYA) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$10.77
$11.25
50-Day Range
$9.91
$11.16
52-Week Range
$9.82
$25.89
Volume
366,228 shs
Average Volume
320,123 shs
Market Capitalization
$186.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About ARYA Sciences Acquisition Corp III

ARYA Sciences Acquisition Corp III does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.

ARYA Stock News Headlines

ARYA Sciences Secures Convertible Sponsor Loan
Arya Sciences Acquisition to Redeem Shares
See More Headlines
Receive ARYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARYA Sciences Acquisition Corp III and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
Holding & Other Investment Offices
Sub-Industry
N/A
Current Symbol
NASDAQ:ARYA
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.30 per share

Miscellaneous

Free Float
N/A
Market Cap
$186.48 million
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Adam Leo Stone (Age 42)
    CEO & Director
  • Mr. Michael Seth Altman C.F.A. (Age 39)
    CFA, CFO & Director
  • Mr. Konstantin Poukalov (Age 37)
    Chief Bus. Officer

ARYA Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of ARYA Sciences Acquisition Corp III own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ARYA Sciences Acquisition Corp III investors own include Trevena (TRVN), Advanced Micro Devices (AMD), BioXcel Therapeutics (BTAI), ChromaDex (CDXC), Chimerix (CMRX), CTI BioPharma (CTIC), DRDGOLD (DRD) and

When did ARYA Sciences Acquisition Corp III IPO?

ARYA Sciences Acquisition Corp III (ARYA) raised $125 million in an initial public offering on Friday, August 7th 2020. The company issued 12,500,000 shares at $10.00 per share. Jefferies and Goldman Sachs acted as the underwriters for the IPO.

This page (NASDAQ:ARYA) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners